Biotech companies are seeing significant pre-market activity this Tuesday, suggesting potential opportunities.
Price swings ahead of the opening bell are being driven by plans to advance market launches alongside acquisitions, financing deals, AI training program launches, and offering closures.
In the Green - Premarket Gainers
On Tuesday, the following stocks were trading significantly higher in the premarket session.
1. Regentis Biomaterials Ltd. (RGNT) - up 124% at $2.912. ENvue Medical, Inc. (FEED) - up 112% at $1.663. Nuvalent, Inc. (NUVL) - up 39% at $122.864. Cartesian Therapeutics, Inc. (RNAC) - up 16% at $6.785. Anbio Biotechnology. (NNNN) - up 10% at $18.976. WORK Medical Technology Group LTD. (WOK) - up 9% at $0.117. Propanc Biopharma, Inc. (PPCB) - up 8% at $1.488. Jasper Therapeutics. (JSPR) - up 7% at $0.509. Precision BioSciences, Inc. (DTIL) - up 6% at $7.1910. Iveda Solutions, Inc. (IVDA) - up 5% at $0.30
In the Red - Premarket Losers
The following stocks were trading lower in the premarket session on Tuesday.
1. Park Ha Biological Technology Co., Ltd. (BYAH) - down 39% at $1.612. MetaVia Inc. (MTVA) - down 23% at $1.723. Bio Green Med Solution, In. (BGMS) - down 15% at $0.934. Bluejay Diagnostics, Inc. (BJDX) - down 14% at $4.515. Clearmind Medicine Inc. (CMND) - down 13% at $3.286. Virax Biolabs Group Limited. (VRAX) - down 11% at $0.187. Armata Pharmaceuticals, Inc. (ARMP) -down 8% at $7.018. Picard Medical, Inc. (PMI) - down 8% at $0.24.9. IDEAYA Biosciences, Inc. (IDYA) - down 7% at $29.1510. BioCardia, Inc. (BCDA) - down 7% at $0.86
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.